Uday Kompella - Oct 18, 2021 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
Director
Signature
/s/ Uday Kompella by Sanjay Subramanian, his attorney-in-fact
Stock symbol
OCGN
Transactions as of
Oct 18, 2021
Transactions value $
-$1,697,614
Form type
4
Date filed
10/20/2021, 06:57 PM
Previous filing
Jul 30, 2021
Next filing
Oct 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCGN Common Stock Sale -$1.68M -200K -41.72% $8.41 279K Oct 18, 2021 By: Kompella LLC F1, F2
transaction OCGN Common Stock Sale -$15.6K -1.73K -0.62% $9.02 278K Oct 20, 2021 By: Kompella LLC F1, F3
holding OCGN Common Stock 551K Oct 18, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $8.12 to $8.81. The Reporting Person undertakes to provide to Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.00 to $9.03. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.